Skip to content

DeepView Snapshot Handheld (DV-H) Comparison Study

DeepView Snapshot Handheld (DV-H) Comparison Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06024512
Acronym
DHA
Enrollment
18
Registered
2023-09-06
Start date
2023-06-13
Completion date
2024-01-25
Last updated
2024-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns

Brief summary

his study is being done to collect pictures of burns using an investigational device called the Spectral MD Deep View Snapshot Handheld (DV-H), similar to a camera. The data collected will be used to assess the performance of the DV-H device, and to determine the device's ability to differentiate healing versus non-healing burn tissue. This device, if approved, is expected to give caregivers a better understanding of what parts of burn wounds will likely not heal on their own and as a tool used by the military in the field. This current study involves the collection of images over the course of your clinical treatment and follow-up according to your routine standard of care. The device will not be used to diagnose or prescribe treatment for your burn

Interventions

DEVICEBurn

This study is being done to collect pictures of burns using an investigational device called the Spectral MD Deep View Snapshot Handheld (DV-H), similar to a camera. The data collected will be used to assess the performance of the DV-H device, and to determine the device's ability to differentiate healing versus non-healing burn tissue. This device, if approved, is expected to give caregivers a better understanding of what parts of burn wounds will likely not heal on their own and as a tool used by the military in the field. This current study involves the collection of images over the course of your clinical treatment and follow-up according to your routine standard of care. The device will not be used to diagnose or prescribe treatment for your burn.

Sponsors

SpectralMD
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

.Age \>18 years and able to give informed consent or have a Legally Authorized Representative (LAR) able to do so; * Life expectancy \> 6 months; * Thermal burn mechanism (flame, scald, or contact); * The Study Burn(s) occurred less than 72 hours prior to the time of first imaging; * Minimum burn wound size for patients is 0.5% TBSA per region * Have 2 - 4 regions of their clinical burn(s) that meet the criteria for a Study Burn; and

Exclusion criteria

* Patients will be excluded if any of the following conditions apply: * Burn pattern distribution isolated to head, face, neck, hands, feet, genitalia, and/or joints; * Subject has burns involving \> 50% total body surface area (TBSA); * Sepsis at the time of enrollment determined by diagnosis made by Principal Investigator or Sub-Investigator; * Immunosuppression/radiation/chemotherapy \< 3 months prior to enrollment; * Concurrent use of investigational products with a known effect on the burn sites; and/or * Any condition that in the opinion of the Investigator may prevent compliance with the study requirements or compromise subject safety.

Design outcomes

Primary

MeasureTime frameDescription
DeepView Snapshot Handheld (DV-SSH) Comparison Study Protocol3 monthsThe primary objective of this study is to demonstrate that the proposed SA-MSI sensor is equivalent or better than the current LC-MSI sensor. To conduct this test, we will compare the performance of the burn assessment AI algorithm using the image sensor as input data to the same Algorithm using the lens cluster data as an input.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026